Download PDF
Thromb Haemost 2011; 105(01): 202-205
DOI: 10.1055/s-0037-1609004
Editors Choice
Schattauer GmbH

Clinical and basic science articles from Thrombosis and Haemostasis

Gregory Y. H. Lip
1   University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK
,
Christian Weber
2   Institute for Prevention of Cardiovascular Disease, Ludwig-Maximilians-University, Munich, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
15 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Sibbing D, Morath T, Stegherr J. et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thromb Haemost 2009; 101: 714-719.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Montalescot G, Sideris G, Cohen R. et al. Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study. Thromb Haemost 2010; 103: 213-223.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Munnix IC, Cosemans JM, Auger JM. et al. Platelet response heterogeneity in thrombus formation. Thromb Haemost 2009; 102: 1149-1156.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Ahrens I, Lip GY, Peter K. New oral anticoagulant drugs in cardiovascular disease. Thromb Haemost 2010; 104: 49-60.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Ufer M. Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development. Thromb Haemost 2010; 103: 572-585.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Wolowacz SE, Roskell NS, Plumb JM. et al. Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis. Thromb Haemost 2009; 101: 77-85.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Roskell NS, Lip GY, Noack H. et al. Treatments for stroke prevention in atrial fibrillation: A network meta-analyses and indirect comparisons versus dabigatran etexilate. Thromb Haemost 2010; 104: 1106-1115.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Olsson SB, Rasmussen LH, Tveit A. et al. Safety and tolerability of an immediate-release formulation of theoral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation. Thromb Haemost 2010; 103: 604-612.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Weitz JI, Connolly SJ, Patel I. et al. Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation. Thromb Haemost 2010; 104: 633-641.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Diamantopoulos A, Lees M, Wells PS. et al. Cost-effectiveness of rivaroxaban versus enoxaparin for the prevention of postsurgical venous thromboembolism in Canada. Thromb Haemost 2010; 104: 760-770.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Samama MM, Amiral J, Guinet C. et al. An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma. Thromb Haemost 2010; 104: 1078-1079.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Samama MM, Martinoli JL, LeFlem L. et al. Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor. Thromb Haemost 2010; 103: 815-825.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Samama MM, Amiral J, Guinet C. et al. An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma. Thromb Haemost 2010; 104: 1078-1079.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 van Ryn J, Stangier J, Haertter S. et al. Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010; 103: 1116-1127.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Bresin E, Gastoldi S, Daina E. et al. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies. Thromb Haemost 2009; 101: 233-238.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Lip GY, Huber K, Andreotti F. et al. European Society of Cardiology Working Group on Thrombosis.. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting -a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Thromb Haemost 2010; 103: 13–28. Erratum in: Thromb Haemost 2010; 104: 653.
    PubMedGoogle Scholar
  • 17 Lip GY. Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at ‘moderate risk’ [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice. Thromb Haemost 2010; 103: 683-685.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Gorin L, Fauchier L, Nonin E. et al. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1. Thromb Haemost 2010; 103: 833-840.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Leroyer AS, Anfosso F, Lacroix R. et al. Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angio-genesis. Thromb Haemost 2010; 104: 456-463.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Bai L, Gabriels K, Wijnands E. et al. Low- but not high-dose FK506 treatment confers atheroprotection due to alternative macrophage activation and unaffected cholesterol levels. Thromb Haemost 2010; 104: 143-150.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Hristov M, Leyendecker T, Schuhmann C. et al. Circulating monocyte subsets and cardiovascular risk factors in coronary artery disease. Thromb Haemost 2010; 104: 412-414.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Beckers CM, van Hinsbergh VW, van Nieuw Amerongen GP. Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb Haemost 2010; 103: 40-55.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Seijkens T, Engel D, Tjwa M. et al. The role of CD154 in haematopoietic development. Thromb. Haemost 2010; 104: 693-701.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Aidoudi S, Bikfalvi A. Interaction of PF4 (CXCL4) with the vasculature: A role in atherosclerosis and angiogenesis. Thromb Haemost 2010; 104: 941-948.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Konishi N, Hiroe K, Kawamura M. Differential effects of TAK-442, a novel orally active direct factor Xa inhibitor, and ximelagatran, a thrombin inhibitor, on factor V-mediated feedback on coagulation cascade and bleeding. Thromb Haemost 2010; 104: 504-513.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Fuchs C, Ladwig E, Zhou J. et al. Argatroban administration reduces leukocyte adhesion and improves capillary perfusion within the intestinal microcirculation in experimental sepsis. Thromb Haemost 2010; 104: 1022-1028.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Kuijpers MJ, Gilio K, Reitsma S. et al. Complementary roles of platelets and coagulation in thrombus formation on plaques acutely ruptured by targeted ultrasound treatment: a novel intravital model. J Thromb Haemost 2009; 07: 152-161.
    CrossrefPubMedGoogle Scholar
  • 28 Kanno Y, Matsuno H, Kawashita E. et al. Urokinase-type plasminogen activator receptor is associated with the development of adipose tissue. Thromb Haemost 2010; 104: 1124-1132.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Lederman M. Haemophilia, human immunodeficiency virus and human immunodeficiency virus pathogenesis. Thromb Haemost 2010; 104: 911-914.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 30 Müthing J, Schweppe CH, Karch H. et al. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb Haemost 2009; 101: 252-264.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Deroo S, Deatrick KB, Henke PK. The vessel wall: A forgotten player in post thrombotic syndrome. Thromb Haemost 2010; 104: 681-692.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Soehnlein O, Zernecke A, Weber C. Neutrophils launch monocyte extravasation by release of granule proteins. Thromb Haemost 2009; 102: 198-205.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Ransohoff KJ, Wu JC. Advances in cardiovascular molecular imaging for tracking stem cell therapy. Thromb Haemost 2010; 104: 13-22.
    Article in Thieme ConnectPubMedGoogle Scholar